Group I Paks as therapeutic targets in NF2-deficient meningioma.
Chow HY, Dong B, Duron SG, Campbell DA, Ong CC, Hoeflich KP, Chang LS, Welling DB, Yang ZJ, Chernoff J.
Chow HY, et al. Among authors: chernoff j.
Oncotarget. 2015 Feb 10;6(4):1981-94. doi: 10.18632/oncotarget.2810.
Oncotarget. 2015.
PMID: 25596744
Free PMC article.